Home » Newsletters » BioWorld Asia

BioWorld Asia

June 7, 2000

View Archived Issues

Biofrontera Raises DM23M For Expression, Biocomputing Work

Antibody Against CD40 Shows Promise In Mouse Model Of RA

EFPIA Plans To Set Up Group To Assist Biotech Companies

Evolutec Laying Groundwork For Work Based On Tick Saliva

EU Directive On Clinical Trials Designed To Streamline Rules

IDM Licenses IL-13 Rights In Deal With Sanofi-Synthilabo

Teva's Copaxone Gains UK Approval Recommendation

One Of Four Phase II Studies Of Xenova's XR5000 Falls Short

EU, U.S. Officials Expect Better Understanding At Next Summit

Series Of New Hi-Tech Funds Will Benefit Israeli Biotech

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...